Latest / Follow the Lies: Fraud & Deceit Uncovered / Episode 5: The $9 Billion Blood Test Lie — How Charisma Fooled Silicon Valley
Transcript
- Kevin Barrows: 2015. Minions is dominating the box office. Adele is making a massive comeback with Hello and wearable technology is exploding with the launch of the Apple Watch. Meanwhile, one name is everywhere. Elizabeth Holmes. She's on the cover of Forbes, Fortune and Inc. magazines. They're calling her the youngest self-made female billionaire in history. Her company, Theranos, is valued at $9 billion. She promised us something that sounds almost too good to be true. A revolutionary blood testing machine that can run hundreds of different tests from a single droplet of blood. No more needles. No more big vials. Faster, cheaper, and more accurate than anything the world had ever seen. Major hospitals are interested. The U.S. military is paying attention. Big name investors are pouring in money. And Walgreens is about to put Theranos Mini Labs inside thousands of stores across America. so anyone can walk in and get tested on the spot. Then the cracks start to show. One investigative journalist begins asking tough questions. A few brave employees finally speak up. What they reveal is shocking. The technology doesn't actually work. The machines give wildly inaccurate results. Some tests are being secretly run on commercial lab equipment and then falsified. And the company is allegedly bullying scientists and threatening whistleblowers to keep the lie alive. This wasn't just Silicon Valley hype. This was one of the most daring corporate frauds in modern business history. Today, we follow the lies from a Stanford dropout's garage all the way to a $9 billion valuation built on deception. And why disruptive innovation can sometimes be the most dangerous kind of lie? Welcome to Follow the Lies, thrown to seed uncovered. I'm Kevin Barrows. Before we dig deeper, let me tell you why this case hits close to home for me. I'm a former FBI special agent and lead case agent on two of the largest white collar investigations in US history. Operation UPDIC, which took down organized crime on Wall Street, and the Cummings Identity Theft Ring. Today I'm a partner at Renaissance Associates, where I investigate complex fraud and misconduct for corporations, institutions, law firms, and individuals. I also co-hosted the Smithsonian Channel's stocky series, Sports Detectives, where we expose forgery in the sports memorabilia world. I've spent decades watching how lies can hide behind charisma, bold vision, and the promise of revolutionary change. I've seen intelligent, ambitious people convince themselves, and everyone around them, that the usual rules don't apply when the stakes are high and the money's flowing fast. On Follow the Lies, we go inside these high stakes investigations across the full deception spectrum. From corporate fraud to sports scams and historical mysteries, to show exactly how trust gets destroyed, when deception takes over. Now let's go back to the beginning, with a 19-year-old college dropout who believed she was going to change medicine forever. In 2003, a Stanford dropout named Elizabeth Holmes had a bold idea she believed would revolutionize health care. She wanted to create a machine that could run hundreds of blood tests from just a few drops taken from a finger prick. No more needles, no more big vials of blood, and results delivered in minutes instead of days. It would be faster, cheaper, and more convenient than anything the world had ever seen. She called the company Theranos, a blend of therapy and diagnosis. Holmes pitched her vision with the intensity of a true believer. She wore black turtlenecks like Steve Jobs, spoke in grand revolutionary terms, and convinced some of the most powerful people in the country that she was about to disrupt an entire industry. Helping drive that vision, and eventually becoming one of the most powerful figures inside the company, was Ramesh Sunny Balwani. A decade older than Holmes, Balwani had a background in software and business. He became Theranos' president and chief operating officer. He was also Holmes' romantic partner for several years. Together, they formed a formidable and controlling leadership duo. By the early 2010s, the hype had become unstoppable. Major investors poured in hundreds of millions. The board was stacked with political heavyweights. Henry Kissinger, George Shultz, and others. Rupert Murdoch, the Walton family, and even the U.S. military showed serious interest. Theranos struck a landmark deal with Rawgreens to place its miniature blood testing labs inside thousands of pharmacies across America. Walgreens invested over $150 million and planned a nationwide rollout that would have put Theranos machines in stores where everyday people could walk in and get tested on the spot. At its peak, Theranos had a multi-billion dollar valuation. Elizabeth Holmes, still in her early 30s, was personally worth billions on paper. and was celebrated as the youngest self-made female billionaire in history. But behind the glamorous presentations, the sleek black and white labs, and the carefully choreographed media tours, the technology simply didn't work. The machines, nicknamed Edison, were unreliable at best. They frequently produced wildly inaccurate or completely erroneous results. When the devices failed during demonstrations, employees were allegedly instructed to run patient samples on commercial laboratory machines in secret. and then falsify the data to make it look like the Theranos device had produced the results. The company culture was intense and often toxic. Employees operated under extreme secrecy. They were forbidden from discussing their projects with one another. Quality control was reportedly ignored or bypassed. Scientists and engineers who raised concerns about the technology were allegedly intimidated, demoted, or fired. Questioning the vision was treated as disloyalty. Both Holmes and Balwani were said to rule with an iron fist, demanding absolute loyalty and punishing dissent. The lies were layered and deliberate. Fake demonstrations for investors and partners, misleading claims made the regulators, and a carefully constructed public image that hid the truth for many years. And the consequences weren't just financial. People were put in harm's way, and real patients paid a heavy price. One pregnant woman received Theranos results showing her HCG levels had plummeted, a clear sign she was miscarrying again. She was devastated and began preparing for another loss until conventional lab tests confirmed she was still carrying a healthy baby. Another woman was told by a Theranos test that she was HIV positive. She spent days in panic, telling close friends and family and preparing for a life-changing diagnosis until a proper lab test proved it was false. The psychological toll was severe. A doctor became so alarmed by a theranose result suggesting his patient was at imminent risk of a heart attack that he rushed her to the emergency room, only for the hospital tests to show the patient was perfectly fine. A breast cancer survivor received results indicating a high risk of recurrence of a rare tumor. She panicked and underwent additional testing and medical appointments before conventional labs showed the results were wrong. She later described the experience as very traumatic. The stories go on and on. These weren't isolated mistakes. They were symptoms of a deeper deception, a company that prioritized hype, valuation, and control over accuracy and patient safety. That was the scheme. But how do you uncover a fraud this massive when the lies are wrapped in revolutionary vision and backed by some of the most powerful people in the country? That's when the real investigation finally began. The House of Cards began to crumble in the fall of 2015, thanks largely to one determined investigative journalist at the Wall Street Journal. His name was John Carirou. He started hearing whispers from former Theranos employees, scientists and lab technicians who said the technology simply didn't work the way Elizabeth Holmes was describing it to the world. Many of them were afraid to speak on the record, fearing legal retaliation from the company. One lab scientist, Erica Chung, Later testified, I was terrified. I felt like I was working in a place where people were going to get hurt. Harry Roo kept digging. He interviewed more than a dozen insiders, reviewed internal documents, and slowly pieced together the truth. The Edison machines often produced wildly inaccurate or completely erroneous results. Tyler Schultz, a young lab associate and grandson of board member George Schultz, described how he was warned that if he left the company, quote, I would be personally sued and my career would be over. Others spoke of Sonny Balwani screaming at staff and telling them they were stupid if they questioned the technology. One lab technician later said, we were told to fix the results if the machine gave the wrong answer. It wasn't science. It was theater. Carrie Rue's explosive story, published in October 2015, sent shockwaves through Silicon Valley and beyond. The fallout was swift and brutal. One of the most damning revelations was how Theranos handled quality control. Erica Chung testified that the Edison machine's failed quality control test at an alarming rate, sometimes as high as 100 % on certain blood tests. Internal emails and whistleblower reports revealed that Holmes and Balwani personally knew about the high failure rates as early as 2014, but continued to push the technology forward. Adam Rosendorff, a former lab director, resigned in late 2014 because he felt pressured to vouch for tests he wasn't confident in and saw far more doctor complaints about Theranos results than any previous lab he had ever worked at. Instead of fixing the machines, employees were allegedly instructed to delete outlier results or simply run the samples on commercial analyzers in the back room and report these as if they came from the Edison. This wasn't a one-off shortcut. It was a systematic practice. When regulators from the Centers for Medicare and Medicaid Services finally inspected the Newark lab in late 2015, they found such serious deficiencies that they declared the lab posed immediate jeopardy to patient health and safety. That inspection ultimately led to Holmes and Balwani being banned from operating any laboratory for two years. Major partners started to pull away. Walgreens quietly distanced itself and Safeway eventually walked away from its planned nationwide rollout. Theranos' multi-billion dollar valuation collapsed almost overnight. But the real turning point came when the federal authorities got involved. The SEC opened the civil investigation into possible securities fraud. At the same time, the U.S. Attorney's Office and the FBI launched a criminal probe. They examined not only the misleading claims made to investors, but also whether patient test results had been falsified in ways that could have harmed real people. In June 2018, Federal prosecutors unsealed criminal charges against Elizabeth Holmes and Ramesh Sunny Balwani. Balwani was deeply involved in the day-to-day operations and was accused alongside Holmes of orchestrating the years-long scheme to defraud investors, doctors, and patients through wire fraud and conspiracy. The trial, which began in 2021, showed exactly how the fraud operated. Former employees testified about falsified demonstrations for investors and partners. manipulated test results, and a workplace culture designed to silence dissent. Whistleblowers like Erica Chung and Tyler Schulz described being threatened with lawsuits, intense pressure to stay quiet, and even being followed or monitored. One witness after another described how Holmes personally pressured staff to produce positive results even when the machines were failing, with Balwani often enforcing that pressure behind the scenes. Theranos wasn't just a business failure. It was a stark reminder of how charisma, secrecy, and fear could sustain a massive lie for years. On the deception spectrum, Theranos sits at the very high end. Systemic fraud built on hype, intimidation, and the deliberate misrepresentation of technology that never worked as advertised. What made it especially dangerous was the way Holmes and Balwani weaponized their vision. They didn't just sell a product, they sold a revolution. And when people buy into a revolution, they often stop asking the hard questions. After months of testimony, the jury reached its verdict in January 2022. Elizabeth Holmes was convicted on four counts of wire fraud conspiracy. In November 2022, she was sentenced to more than 11 years in federal prison. Sonny Balwani was convicted on 12 counts and sentenced to nearly 13 years. It was a stunning fall from grace for the woman once celebrated as the next Steve Jobs and for the man who had been her closest partner in both business and life. The judge, in delivering the sentence, called Theranos a cautionary tale for Silicon Valley and stressed that the tech industry, built on bold ideas and rapid innovation, ultimately rests on one fragile foundation, trust. When that trust is broken through deception and hype, the consequences go far beyond lost investments. They erode confidence across the entire industry and can cause real harm to ordinary people who depend on honest science and honest leadership. What made the case particularly troubling is how many insiders later admitted they had doubts but stayed silent out of fear or loyalty. The trial revealed a workplace where questioning the technology was treated as betrayal and where the pressure to deliver positive results often overrode basic scientific integrity. What I find most concerning, having spent decades investigating fraud, is how so many powerful people wanted to believe the story. The combination of charisma, secrecy, fear, and massive financial incentives kept the deception alive for longer than it should have, until the evidence finally became impossible to ignore. In many ways, it reminded me of Madoff. The lies survived for so long because of that same powerful desire to believe, and the very real fear of challenging a charismatic, almost untouchable leader. The case also exposed something deeper about Silicon Valley at the time. The dangerous tendencies of value, vision and charisma over substance and verification. When hype moves faster than reality, and when fear keeps people silent, deception can scale at a breakneck speed. In the end, the real victims weren't just the investors who lost billions. They were the patients whose health decisions were based on faulty results. the employees who lived in constant fear, and the public trust that was eroded yet again. This is why due diligence and a willingness to challenge a compelling narrative matters so much. No matter how revolutionary something sounds, the truth still has to hold up under scrutiny. That's a lesson I carry with me from every major case I've worked, and one I hope listeners take away from this episode as well. Today's lie detector tip is about spotting too good to be true revolutionary claims. When someone promises to completely upend an industry with breakthrough technology, don't get swept up in the vision. Slow down and ask the hard questions early, then test the credibility of the answers. In every case, even when you feel a witness is telling the truth, it's imperative to corroborate the information to the extent possible. Show me the independent data. Let me speak directly to the scientists who built it. What happens when the technology fails under real conditions? Who has independently verified the results? In De Theranos' too many smart, powerful people bought the dream without demanding real proof. Red flags were everywhere. Extreme secrecy about how the machines actually worked. Wildly inconsistent test results. And a company culture that punished anyone who dared to ask questions. My advice is simple but powerful. Whether it's a startup pitch, a hot new investment, or even a miracle product that sounds life-changing. Trust verifiable data and independent testing far more than charisma or bold vision. If they won't let you see how it really works, or they become defensive when you push for proof, that's often the biggest clue of all. I've seen this play out on a smaller scale in my own investigations. One case involved a private stock offering for a company that claimed to have developed a revolutionary technology solution to the Y2K Millennium Bug. For those too young to remember, this was massive global concern at the time. The fear that computers worldwide would fail when the date rolled over from 1999 to 2000. The glossy documents were beautifully written and the promoters could sell sand in the desert. But just like the Edison machines at Theranos, the technology was little more than an unrealistic dream wrapped in hype. It ultimately resulted in significant investor losses. I'll share more practical techniques like this in future episodes. From a Stanford dropout's garage to a $9 billion valuation built on lies, the Theranos story shows how deception can scale when hype outruns reality and how quickly it can hurt real people when the truth finally comes out. Has a revolutionary idea, investment or company ever raised red flags for you? Or have you ever seen charisma used to hide uncomfortable truths? If so, I'd genuinely like to hear your story. Send it to Kevin at followthelivespodcast.com. It might even become a future episode. And if you want to sharpen your own ability to spot lies, whether in business pitches, everyday conversations, or high stakes situations, I put together a free guide called Seven Proven Strategies to Spot Lies and Uncover the Truth in Any Interview. It's short, practical, and based on techniques I've used for years. You can grab it right now, free, at followthelivespodcast.com. If you're enjoying these deep dives, Please hit subscribe, leave a rating or review and tap the bell so you never miss an episode. One more thing, Follow the Lies is now featured on the World Podcast Network. If you enjoy the show, I'd really appreciate it if you follow us there too. Thanks for listening. Until next time, follow the lies.